Literature DB >> 9592706

[Coronary spasm--a clinically relevant problem?].

W Auch-Schwelk1.   

Abstract

Coronary spasms are defined as reversible coronary stenosis, which limits coronary blood flow under resting conditions. The demonstration of either spontaneous or provoked coronary spasm proves coronary hypercontractility and thus the diagnosis of variant angina. Several stimuli can provoke coronary vasospasm, but the highest sensitivity and specificity has been shown with ergonovine. Alternatively acetylcholine or with less sensitivity, but high specificity, hyperventilation may be employed. Typically coronary vasospasm presents with angina pectoris at rest; the manifestation with myocardial infarction or syncope are of great clinical importance. The prevalence of the disease is unknown due to the rarely performed provocation tests in Western countries. The incidence of positive test results strongly depends on the symptoms of the patients; from 0% in patients without any evidence for myocardial ischemia up to 54% in patients with typical angina at rest have been observed. Coronary vasospasm is closely related to atherosclerotic coronary artery disease, since intravascular ultrasound studies reveal atherosclerotic plaques in almost any spastic segment. Risk factors for coronary artery disease and coronary vasospasm, however, differ profoundly. For the latter cigarette smoking is the only established risk factor. Although several candidates and predisposing factors (serotonin, histamine, thromboxane, endothelin) have been described, the mediators and the pathogenesis of the disease remains unknown. Endothelial dysfunction alone is not sufficient to explain the features of variant angina. Some evidence supports the hypothesis of local inflammation. The mortality in variant angina depends on the extent of the coronary artery disease. Pure coronary vasospasm does not lead to increased mortality; patients with highly active disease presenting with syncope may have an increased risk. Medical treatment should include long-acting calcium antagonists or nitrates, beta-blockers may even favor the occurrence of ischemic attacks. Although the benefit has not been proven, the use of aspirin may considered in highly active disease.

Entities:  

Mesh:

Year:  1998        PMID: 9592706     DOI: 10.1007/BF03044541

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  78 in total

1.  Smoking is a risk factor for coronary spasm in young women.

Authors:  D G Caralis; U Deligonul; M J Kern; J D Cohen
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

Review 2.  Stenting for treatment of coronary vasospasm.

Authors:  A Rabinowitz; A Dodek; R G Carere; J G Webb
Journal:  Cathet Cardiovasc Diagn       Date:  1996-12

3.  Frequency of symptoms suggestive of dynamic coronary artery disease in patients referred for coronary angiography.

Authors:  R W Nesto; S W Zarich; G J Kowalchuk; A E Kenigsberg; S W Shurmur; L S McAuliffe
Journal:  Am J Cardiol       Date:  1989-12-01       Impact factor: 2.778

4.  Hyperventilation as a specific test for diagnosis of coronary artery spasm.

Authors:  K Nakao; M Ohgushi; M Yoshimura; K Morooka; K Okumura; H Ogawa; K Kugiyama; Y Oike; K Fujimoto; H Yasue
Journal:  Am J Cardiol       Date:  1997-09-01       Impact factor: 2.778

5.  Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm.

Authors:  K Okumura; H Yasue; K Matsuyama; K Goto; H Miyagi; H Ogawa; K Matsuyama
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

6.  Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine.

Authors:  Y Suzuki; S Tokunaga; S Ikeguchi; S Miki; T Iwase; T Tomita; T Murakami; C Kawai
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

7.  Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients.

Authors:  P Chevalier; A Dacosta; P Defaye; T Chalvidan; E Bonnefoy; G Kirkorian; K Isaaz; B Denis; P Touboul
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

8.  Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments.

Authors:  M Yamagishi; K Miyatake; J Tamai; S Nakatani; J Koyama; S E Nissen
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

9.  Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P.

Authors:  H Yamamoto; H Yoshimura; M Noma; H Kai; S Suzuki; T Tajimi; M Sugihara; Y Kikuchi
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

10.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.

Authors:  M E Bertrand; J M LaBlanche; P Y Tilmant; F A Thieuleux; M R Delforge; A G Carre; P Asseman; B Berzin; C Libersa; J M Laurent
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  1 in total

1.  'Action potential-like' ST elevation following pseudo-Wellens' electrocardiogram.

Authors:  Fatih Oksuz; Baris Sensoy; Fatih Sen; Ethem Celik; Ozcan Ozeke; Orhan Maden
Journal:  Indian Heart J       Date:  2015-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.